Proceeding contribution from Andy Burnham (Labour) in the House of Commons on Tuesday, 25 April 2017. It occurred during Adjournment debate on Contaminated Blood.
Contaminated Blood
That was the direct content of the Stanford letter. There was a worry that the NHS was using such products in a completely different context, not understanding the difference between the two systems. That was the Stanford letter.
I am not standing here claiming to be an expert on all the papers, because I am not; I am saying what I know, from the people I have spoken to, to be wrong, and linking that to the documents in order to say what I believe to be the case. I may not be right, but we need to find out whether I am right, and that is the point that I will be putting to the Government.
Secondary information
- Type
- Proceeding contribution
- Reference
- 624 c1078
- Session
- 2016-17
- Chamber / Committee
- House of Commons chamber
- Subjects
- Compensation Contamination Blood Diseases Maladministration Negligence Blood transfusions
- Link
- View this Proceeding contribution on hansard.parliament.uk
Librarians' tools
- Timestamp
- 2022-08-30 09:16:32 +0100
- URI
- http://hansard.intranet.data.parliament.uk/Commons/2017-04-25/17042540000360
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2017-04-25/17042540000360
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2017-04-25/17042540000360